Dellepiane F, Moltoni G, Ronci S, Guarnera A, Rossi-Espagnet M, Digilio M
Biomedicines. 2025; 12(12.
PMID: 39767685
PMC: 11673543.
DOI: 10.3390/biomedicines12122779.
Pan Y, Ren B, Chen L, Li Q
Front Pediatr. 2024; 12:1419976.
PMID: 39687712
PMC: 11646758.
DOI: 10.3389/fped.2024.1419976.
Thompson M
Genes (Basel). 2024; 15(6).
PMID: 38927651
PMC: 11203049.
DOI: 10.3390/genes15060715.
Ranjan A, Alam M, Kumar V, Kumar R, Saifullah K, Fakih S
Cureus. 2024; 16(5):e60737.
PMID: 38903302
PMC: 11187727.
DOI: 10.7759/cureus.60737.
Thompson M, Knaus A
Genes (Basel). 2024; 15(5.
PMID: 38790248
PMC: 11121671.
DOI: 10.3390/genes15050619.
Bilateral Glaucoma as Possible Additional Feature for -Associated Hyperphosphatasia.
Obaid O, Batawi R, Alqurashi H, Ewis T, Obaid A
Case Rep Genet. 2024; 2024:3561555.
PMID: 38558875
PMC: 10981546.
DOI: 10.1155/2024/3561555.
PIGO-CDG: A case study with a new genotype, expansion of the phenotype, literature review, and nosological considerations.
Starosta R, Kerashvili N, Pruitt C, Schultz M, Boyer S, Morava E
JIMD Rep. 2023; 64(6):424-433.
PMID: 37927489
PMC: 10623102.
DOI: 10.1002/jmd2.12396.
A novel homozygous PIGO mutation associated with severe infantile epileptic encephalopathy, profound developmental delay and psychomotor retardation: structural and 3D modelling investigations and genotype-phenotype correlation.
Aguech A, Sfaihi L, Alila-Fersi O, Kolsi R, Tlili A, Kammoun T
Metab Brain Dis. 2023; 38(8):2665-2678.
PMID: 37656370
DOI: 10.1007/s11011-023-01276-6.
Characteristics of Neuroimaging and Behavioural Phenotype in Polish Patients with PIGV-CDG-An Observational Study and Literature Review.
Hutny M, Lipinski P, Jezela-Stanek A
Genes (Basel). 2023; 14(6).
PMID: 37372388
PMC: 10298423.
DOI: 10.3390/genes14061208.
Excluding Digenic Inheritance of and Variants in Mabry Syndrome (OMIM 239300) Patient: Phenotypic Spectrum Associated with Gene Variants in Hyperphosphatasia with Mental Retardation Syndrome-3 (HPMRS3).
Thompson M, Li X, Spencer-Manzon M, Andrade D, Murakami Y, Kinoshita T
Genes (Basel). 2023; 14(2).
PMID: 36833286
PMC: 9957281.
DOI: 10.3390/genes14020359.
Hyperphosphatasia with mental retardation syndrome 3: Cerebrospinal fluid abnormalities and correction with pyridoxine and Folinic acid.
Messina M, Manea E, Cullup T, Tuschl K, Batzios S
JIMD Rep. 2023; 64(1):42-52.
PMID: 36636587
PMC: 9830023.
DOI: 10.1002/jmd2.12347.
A Novel PGAP3 Gene Mutation-Related Megalocornea Can Be Misdiagnosed as Primary Congenital Glaucoma.
Alhaidari A, Albakri A, Alhumaidi S
Cureus. 2022; 14(9):e29387.
PMID: 36304370
PMC: 9585391.
DOI: 10.7759/cureus.29387.
Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes.
Carmody L, Blau H, Danis D, Zhang X, Gourdine J, Vasilevsky N
Orphanet J Rare Dis. 2020; 15(1):40.
PMID: 32019583
PMC: 7001271.
DOI: 10.1186/s13023-020-1313-0.
Clinical, genetic, and molecular characterization of hyperphosphatasia with mental retardation: a case report and literature review.
Farraj L, Daoud Khatoun W, Abou Chebel N, Wakim V, Dawali K, Ghassibe-Sabbagh M
Diagn Pathol. 2019; 14(1):123.
PMID: 31684969
PMC: 6829978.
DOI: 10.1186/s13000-019-0902-5.
Hyperphosphatasia with mental retardation syndrome, expanded phenotype of related disorders.
Altassan R, Fox S, Poulin C, Buhas D
Mol Genet Metab Rep. 2018; 15:46-49.
PMID: 30023290
PMC: 6047459.
DOI: 10.1016/j.ymgmr.2018.01.007.
Rare Noncoding Mutations Extend the Mutational Spectrum in the PGAP3 Subtype of Hyperphosphatasia with Mental Retardation Syndrome.
Knaus A, Awaya T, Helbig I, Afawi Z, Pendziwiat M, Abu-Rachma J
Hum Mutat. 2016; 37(8):737-44.
PMID: 27120253
PMC: 5084765.
DOI: 10.1002/humu.23006.
A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a neurodegenerative X-linked epileptic encephalopathy with systemic iron-overload.
Swoboda K, Margraf R, Carey J, Zhou H, Newcomb T, Coonrod E
Am J Med Genet A. 2013; 164A(1):17-28.
PMID: 24259288
PMC: 4349522.
DOI: 10.1002/ajmg.a.36189.
PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
Krawitz P, Murakami Y, Riess A, Hietala M, Kruger U, Zhu N
Am J Hum Genet. 2013; 92(4):584-9.
PMID: 23561847
PMC: 3617374.
DOI: 10.1016/j.ajhg.2013.03.011.
TNAP and EHD1 are over-expressed in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier properties.
Deracinois B, Duban-Deweer S, Pottiez G, Cecchelli R, Karamanos Y, Flahaut C
PLoS One. 2012; 7(10):e48428.
PMID: 23119012
PMC: 3485243.
DOI: 10.1371/journal.pone.0048428.
Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.
Krawitz P, Murakami Y, Hecht J, Kruger U, Holder S, Mortier G
Am J Hum Genet. 2012; 91(1):146-51.
PMID: 22683086
PMC: 3397269.
DOI: 10.1016/j.ajhg.2012.05.004.
